Interestingly, higher incidence of diabetic retinopathy (DR) complications was noted in patients taking semaglutide (3.0%) compared to placebo (1.5%) in clinical trials, with greater risk in those with a history of DR [32]
Above 50, use a 1.0 ml syringe
Founded in 2019, the platform differentiates itself through ABOM-certified obesity medicine physicians
It's hard to ignore all the buzz about GLP-1 medications, and now there's a growing class of GLP-1 supplements popping up everywhere
No separate consultation fee
Given the rapidly increasing use of these medications, even a modest reduction in cancer incidence could have important public health implications. Aparna Kamat, MD When asked how GLP-1s might help lower obesity-related cancer risk, Kamat said its probably a combination of weight loss and other factors